Biopharma companies with GLP-1 (glucagon-like peptide-1) analogs, which have become a new trend in the obesity treatment market long dominated by appetite suppressants and fat-absorbance inhibitors, are upgrading their treatments
[13] [14] BPC-157 has been widely used both by athletes and among the general public, mainly for recovery from injury or stimulating healing in chronic conditions, [15] [12] [16] [17] but there is as yet only very limited human trial data on efficacy and only a few preliminary safety studies
[Oral semaglutide: why we can no longer do without it?] [PMID: 40292501] Laboratory literature summary: [Oral semaglutide: why we can no longer do without it?]
I think that could maybe be a good way to think about it, because I think saying that GLP-1 is anti-inflammatory, I think that that's wrong because that's more for agents that have a really strong effect on one particular inflammatory pathway
Perfect attendance at light workouts beats sporadic attendance at intense sessions
Cancellation requires a phone call